Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previously visible study details and related content. The study record information is no longer accessible on the page.
    Difference
    18%
    Check dated 2026-09-23T01:06:21.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays revision v3.7.0, replacing the previous v3.6.6. This indicates the study page has been updated to a newer version.
    Difference
    0.1%
    Check dated 2026-09-16T00:16:10.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a small backend/template update for the study page. This update does not alter the study details, eligibility criteria, or locations; it seems to be a platform version bump.
    Difference
    0.1%
    Check dated 2026-09-01T19:43:10.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    This change updates the page's underlying version from v3.6.4 to v3.6.5, indicating a small maintenance update to the template or platform without modifying the study details.
    Difference
    0.1%
    Check dated 2026-08-11T17:59:09.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a minor software update to the underlying system. This is a technical version bump and does not change the clinical trial details or visible content.
    Difference
    0.1%
    Check dated 2026-07-28T10:53:08.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.3, indicating a minor update to the document history. The change reflects a version bump rather than a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-06-30T00:42:13.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.